88 related articles for article (PubMed ID: 10341341)
1. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
2. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
3. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
4. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
5. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
6. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
7. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
[TBL] [Abstract][Full Text] [Related]
8. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
[TBL] [Abstract][Full Text] [Related]
9. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S
Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of B-cell translocation gene 2 (BTG2) and its function in T-cell immune responses in a transgenic mouse model.
Terra R; Luo H; Qiao X; Wu J
Int Immunol; 2008 Mar; 20(3):317-26. PubMed ID: 18195048
[TBL] [Abstract][Full Text] [Related]
11. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
[TBL] [Abstract][Full Text] [Related]
12. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
14. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling.
Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP
Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated with growth inhibition.
Montagnoli A; Guardavaccaro D; Starace G; Tirone F
Cell Growth Differ; 1996 Oct; 7(10):1327-36. PubMed ID: 8891336
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
17. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
18. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
20. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
